Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
              RSS     Google+        
 

Journal of Leukemia


Review in 3 weeks        Publishing in 72 hours        Open Access
 
ISSN: 2329-6917
 
 
 
HOME » JOURNALS » LEUKEMIA
french  |  English
 
 
 
 
 
 

Upcoming Event

 

About the Journal

Leukemia is malignancy of any cellular element in the blood or bone marrow. Journal of Leukemia (JL) is a peer reviewed medical journal that includes a wide range of fields in leukemias, lymphomas, multiple myeloma, epidemiologic studies and other hematologic malignancies and creates a platform for the authors to make their contribution towards the journal and the editorial office promises peer process for the submitted manuscripts to ensure quality.

 

JL is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in the field and provide  online access without any restrictions or any other subscriptions to researchers worldwide

This scholarly publishing is using Editorial Tracking System to maintain quality in the review process. Editorial Tracking is an online manuscript submission, review and the progress of the article. Review processing is performed by the editorial board members of Journal of Leukemia or outside experts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript. Authors may submit manuscripts and track its progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

 

Journal of Leukemia is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

flyer image
 

The journal is using Editorial manager System for quality in review process. Editorial manager System is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Leukemia or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

 

Submit manuscript at http://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jlu@omicsgroup.biz

 
Journal of Leukemia is organizing 4th World Congress on Cancer Science & Therapy during October20-22, 2014 Chicago, USA with the theme of Exploring the recent Research & Treatment of Cancer.

 

 

Recently published articles

The MET Receptor Tyrosine Kinase as a Therapeutic Target in Multiple Myeloma

Christine M Stellrecht, Shadia Zaman and Varsha Gandhi

 
Human Immunodeficiency Virus Infection and Chronic Myeloid Leukemia: Is there an Association?

Moosa Patel

 
Obesity and Multiple Myeloma: What Do the Data Tell Us?

Rafael Rios Tamayo, Juan Sáinz Perez, Jose Juan Jimenez-Moleon and Manuel Jurado Chacon

 
Plasmocytoid Dendritic Cells Leukemia: A Rare Presentation

Tlamçani Imane, Ghita Yahyaoui, Moncef Amrani Hassani, Salma Benjelloun, Benseddik Najoua, Lhoussine Balouch and Bamou Youssef

 
Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload

Adel A Hagag and Mokhtar Abd Elfatah

 
Is it Time for CD5+ B-cell Malignancies to have a New Taxonomy?

Douglas Smith

 
Adoptive Immunotherapy for Acute Myeloid Leukemia: From Allogeneic Hematopoietic Cell Transplantation to CAR T Cells

Merav Bar

 
Adult Acute Myeloid Leukemia Long-Term Survivors

M. Jennifer Cheng, Christopher S  Hourigan and Thomas J Smith

 
Advances in Leukemia Treatment with Bone Marrow Transplantation

Susumu Ikehara

 
Mystery of Human T-cell Leukemia Virus Type 1: Commentary on Two Viral Genes, Tax and HBZ

Mitsuaki Yoshida

 
State of the Art Review: New Insights in T Cell Prolymphocytic Leukemia

Toby A Eyre, Angela Hamblin and Anna Schuh

 
 
 
 
 
 
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version